IBM is trading at $247.73 (+10.10%) following reports that the company received $1 billion from a proposed $2 billion CHIPS Act quantum-computing package.
- The quantum-funding headline serves as the primary catalyst, directly highlighting IBM’s leadership role in the emerging sector.
- Broader risk appetite and a recovery in market sentiment are providing additional support, with major U.S. indices trading higher on May 21.